Reuters | Dec 16, 2020 13:40
(Adds European futures, updates levels throughout)
* MSCI ex-Japan jumps after 2 days of losses, Nikkei rises
* S&P 500 futures a tad weaker; European futures inch up
* U.S. dollar weakens
* Federal Reserve policy announcement due
* Asia stock markets this year: https://tmsnrt.rs/2zpUAr4
By Swati Pandey
SYDNEY, Dec 16 (Reuters) - Asian stocks were buoyant on
Wednesday and the dollar eased as hopes of effective coronavirus
vaccines and the growing prospect of more U.S. fiscal stimulus
cheered investors ahead of the Christmas holiday season.
In a sign the positive momentum was set to extend, Eurostoxx
50 futures STXEc1 and Germany's Dax futures FDXc1 edged 0.1%
higher, while futures for London's FTSE FFIc1 firmed 0.3%.
MSCI's broadest index of Asia Pacific shares outside of
Japan .MIAPJ0000PUS rose 0.8% after two straight days of
The index, hovering near record highs, is up 3.8% so far in
December and is on track for its best yearly performance since
2017 thanks to generous government and central bank stimulus
around the world.
Australian shares .AXJO rose 0.8% while South Korea's
KOSPI .KS11 was up 0.4% and Japan's Nikkei .N225 added 0.2%.
China's blue-chip CSI 300 index .CSI300 added 0.15% and
Hong Kong's Hang Seng index .HSI climbed 0.86%.
"We expect many emerging market economies to continue to
show positive momentum in 2021 led by Asia," TD Securities wrote
in a note, adding that, on aggregate, they would recover lost
output from 2020.
"China is likely to see a more rapid convergence to
pre-COVID GDP levels."
E-mini futures for the S&P 500 ESc1 were off 0.05%.
Overnight, U.S. and European stocks, gold and oil were
upbeat. The Dow .DJI rose 1.1% while the S&P 500 .SPX and
the Nasdaq .IXIC climbed 1.3% each. .N
Optimism over a $1.4 trillion U.S. spending package
increased after House of Representatives Speaker Nancy Pelosi
invited other top congressional leaders to meet late on Tuesday
to hammer out a deal to be enacted this week.
Progress on the roll-out of vaccines continued after Moderna
Inc's COVID-19 vaccine appeared set for regulatory authorization
The U.S. also expanded its rollout of the newly approved
vaccine developed by Pfizer Inc. PFE.N and BioNTech SE
BNTX.O . "Despite COVID still raging in Europe and the United States,
markets are looking through the near-term risks to economic
growth and focusing on the likely better times in 2021,"
Betashares chief economist David Bassanese wrote in a note.
"Central banks are promising to keep rates low for 1 to 2
years, which is supporting the economy and financial markets and
also provides a ramp for equity price," he added.
Markets will now look to the U.S. Federal Reserve for new
projections on whether the economy will suffer a double-dip
recession or is on the cusp of a vaccine-inspired boom.
The central bank is to release a statement later in the day,
with analysts expecting some guidance on when and how the Fed
might change its bond purchases. Optimism for a trade deal on Brexit also boosted stocks,
while contributing to a weaker dollar against the British pound
and the euro.
The dollar JPY= made a fresh 1-1/2 month low of 103.40
against the Japanese yen as progress toward a spending bill and
COVID-19 relief measures sapped demand for safe assets. It is
down 4.7% this year so far.
Against the euro EUR= , the greenback languished near 2
1/2-year lows and was last at $1.2160 after two straight days of
losses while it was flat at $1.3459 on sterling GBP= .
In commodities, gold prices XAU= rose 0.1% to $1,855.17 an
Gold, regarded as a hedge against inflation and currency
debasement, has risen over 22% so far this year amid
unprecedented government stimulus globally.
Brent crude LCOc1 slipped 8 cents to $50.68 a barrel and
U.S. crude CLc1 fell 6 cents each to $47.56. O/R
Global assets http://tmsnrt.rs/2jvdmXl
Global currencies vs. dollar http://tmsnrt.rs/2egbfVh
Emerging markets http://tmsnrt.rs/2ihRugV
MSCI All Country Wolrd Index Market Cap http://tmsnrt.rs/2EmTD6j
Asia stock markets: https://tmsnrt.rs/2zpUAr4
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds. Get free top of the line technical analysis/predictors.
More content, faster quotes and charts, and a smoother experience is available only on the App.